FLT4 and sarcoma: Since VEGFR-3 is a strong lymphangiogenic factor, one could assume a worse DSS mediated by high expression levels of VEGFR-3 was due to increased lymphangiogenesis and subsequent lymph node metastasis, although this is rare for sarcomas [24], [26].